Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion type Assertion NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_head.
- NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_provenance.
- NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion evidence source_evidence_literature NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_provenance.
- NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion SIO_000772 22617708 NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_provenance.
- NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion wasDerivedFrom befree-2016 NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_provenance.
- NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_assertion wasGeneratedBy ECO_0000203 NP984461.RAwt_4voPOUzGogbOMBrgznQNe3SctY0couGi28Y7znNA130_provenance.